Elective surgeries are canceled or delayed indefinitely as a result of the overwhelming number of Covid-19 patients in hospitals. The majority of orthopaedic procedures, like joint replacements, are elective because they do not have to be done in order to improve the patient's quality of life.

US Arthroscopy Procedures Marketwas experiencing rapid expansion prior to Covid-19, but that expansion has slowed down as a result of the disaster. Investors, who were anticipating a favorable market shift, are now watching as things unravel.

Due to the shifting healthcare landscape, Stryker, one of the industry leaders in orthopaedics, withdrew its 2020 sales growth and earning per share guidance. The majority of orthopaedic procedures as well as the markets for joint replacement and arthroscopy are anticipated to be severely impacted by the pandemic. However, emergency orthopaedic medicine, such as spine and trauma, will see less market disruption. However, the full impact of Covid-19 on the orthopaedics market has not yet been seen. Stryker was all set to complete its $5.4 billion acquisition of Wright Medical, a major player in the market for limb replacements. The FTC had already looked into the deal, and a shareholder lawsuit had been filed against it. Stryker has already noted that these are unprecedented times, despite the fact that there has been no indication that the deal will be canceled.